Proteome Sciences PLC (PRM) — Capital Reinvestment Ratio
Latest as of December 2025:
0.05x
Proteome Sciences PLC (PRM) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow (GBX851.00K) in capital expenditures (GBX39.00K). See how much free cash does Proteome Sciences PLC generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
GBX851.00K
GBX
Capital Expenditures
GBX39.00K
GBX
Data as of
Dec 2025
Most recent filing
Proteome Sciences PLC Capital Reinvestment Ratio (2010–2022)
This chart tracks Proteome Sciences PLC's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Proteome Sciences PLC (2010–2022)
Year-by-year Capital Reinvestment Ratio for Proteome Sciences PLC from 2010 to 2022. For live market cap and broader valuation context, see PRM market cap.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 815.89x | GBX2.14 Million | GBX1.75 Billion | ▼ -62.4% |
| 2021 | 2168.98x | GBX793.00K | GBX1.72 Billion | ▲ +159.3% |
| 2020 | 836.39x | GBX1.58 Million | GBX1.32 Billion | ▲ +3186498.5% |
| 2017 | 0.03x | GBX55.47 Billion | GBX1.46 Billion | ▼ -36.5% |
| 2015 | 0.04x | GBX46.63 Billion | GBX1.93 Billion | ▼ -73.8% |
| 2010 | 0.16x | GBX4.00 Million | GBX631.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow